141 related articles for article (PubMed ID: 8395157)
1. Sera from patients with Lambert-Eaton myasthenic syndrome recognize the beta-subunit of Ca2+ channel complexes.
Rosenfeld MR; Wong E; Dalmau J; Manley G; Egan D; Posner JB; Sher E; Furneaux HM
Ann N Y Acad Sci; 1993 Jun; 681():408-11. PubMed ID: 8395157
[No Abstract] [Full Text] [Related]
2. [Paraneoplastic neurologic syndromes. 2. Lambert-Eaton myasthenic syndrome. 2) Anti-calcium channel antibody and clinical features].
Nakao Y; Motomura M; Suenaga A; Nakamura T; Yoshimura T; Tsujihata M; Ito M; Kono S; Eguchi K
Nihon Naika Gakkai Zasshi; 1998 Apr; 87(4):685-90. PubMed ID: 9627478
[No Abstract] [Full Text] [Related]
3. Do calcium channel autoantibodies cause cerebellar ataxia with Lambert-Eaton syndrome?
Fletcher CF; Lennon VA
Ann Neurol; 2003 Jan; 53(1):5-7. PubMed ID: 12509841
[No Abstract] [Full Text] [Related]
4. Specificity of autoantibodies react with omega-conotoxin MVIIC-sensitive calcium channel in Lambert-Eaton myasthenic syndrome.
Suenaga A; Shirabe S; Nakamura T; Motomura M; Tsujihata M; Matsuo H; Kataoka Y; Niwa M; Itoh M; Nagataki S
Muscle Nerve; 1996 Sep; 19(9):1166-8. PubMed ID: 8761275
[No Abstract] [Full Text] [Related]
5. Calcium channel autoantibodies in Lambert-Eaton myasthenic syndrome.
Leys K; Lang B; Vincent A; Newsom-Davis J
Lancet; 1989 Nov; 2(8671):1107. PubMed ID: 2572837
[No Abstract] [Full Text] [Related]
6. Autoantibody specificities in Lambert-Eaton myasthenic syndrome.
Lang B; Johnston I; Leys K; Elrington G; Marqueze B; Leveque C; Martin-Moutot N; Seagar M; Hoshino T; Takahashi M
Ann N Y Acad Sci; 1993 Jun; 681():382-93. PubMed ID: 8395152
[No Abstract] [Full Text] [Related]
7. Lambert-Eaton syndrome IgG inhibits dihydropyridine-sensitive, slowly inactivating calcium channels in bovine adrenal chromaffin cells.
Blandino JK; Kim YI
Ann N Y Acad Sci; 1993 Jun; 681():394-7. PubMed ID: 8395153
[No Abstract] [Full Text] [Related]
8. The role of autoantibodies in Lambert-Eaton myasthenic syndrome.
Lang B; Waterman S; Pinto A; Jones D; Moss F; Boot J; Brust P; Williams M; Stauderman K; Harpold M; Motomura M; Moll JW; Vincent A; Newsom-Davis J
Ann N Y Acad Sci; 1998 May; 841():596-605. PubMed ID: 9668304
[No Abstract] [Full Text] [Related]
9. [Lambert-Eaton syndrome without calcium channel autoantibodies].
Delpont E; Martin-Moutot N; Brunetto JL; Desnuelle C
Rev Neurol (Paris); 1994; 150(3):244-7. PubMed ID: 7863174
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory action of Lambert-Eaton syndrome IgG on calcium currents in a thyroid C-cell line.
Kim YI; Blandino JK; O'Shaughnessy TJ
Ann N Y Acad Sci; 1993 Jun; 681():398-401. PubMed ID: 8395154
[No Abstract] [Full Text] [Related]
11. Lambert-Eaton syndrome antibodies target multiple subunits of voltage-gated Ca2+ channels.
Hajela RK; Huntoon KM; Atchison WD
Muscle Nerve; 2015 Feb; 51(2):176-84. PubMed ID: 24862203
[TBL] [Abstract][Full Text] [Related]
12. Antibodies against the calcium channel beta-subunit in Lambert-Eaton myasthenic syndrome.
Verschuuren JJ; Dalmau J; Tunkel R; Lang B; Graus F; Schramm L; Posner JB; Newsom-Davis J; Rosenfeld MR
Neurology; 1998 Feb; 50(2):475-9. PubMed ID: 9484375
[TBL] [Abstract][Full Text] [Related]
13. Lambert-Eaton myasthenic syndrome. Antigenicity of recombinant human P/Q-type calcium channel alpha 1 subunit putative ion pore region (domain IV, S5-S6).
Black JL; Griesmann GE; Erickson J; Kryzer TJ; Lamke GT; Lennon VA
Ann N Y Acad Sci; 1998 May; 841():691-5. PubMed ID: 9668316
[No Abstract] [Full Text] [Related]
14. Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome.
Mason WP; Graus F; Lang B; Honnorat J; Delattre JY; Valldeoriola F; Antoine JC; Rosenblum MK; Rosenfeld MR; Newsom-Davis J; Posner JB; Dalmau J
Brain; 1997 Aug; 120 ( Pt 8)():1279-300. PubMed ID: 9278623
[TBL] [Abstract][Full Text] [Related]
15. Antigens associated with N- and L-type calcium channels in Lambert-Eaton myasthenic syndrome.
el Far O; Marquèze B; Leveque C; Martin-Moutôt N; Lang B; Newsom-Davis J; Yoshida A; Takahashi M; Seagar MJ
J Neurochem; 1995 Apr; 64(4):1696-702. PubMed ID: 7891097
[TBL] [Abstract][Full Text] [Related]
16. Calcium channel autoantibody and non-small-cell lung cancer in patients with Lambert-Eaton syndrome.
Sher E; Comola M; Nemni R; Canal N; Clementi F
Lancet; 1990 Feb; 335(8686):413. PubMed ID: 1968140
[No Abstract] [Full Text] [Related]
17. [Lambert-Eaton myasthenic syndrome].
Takamori M
Tanpakushitsu Kakusan Koso; 1998 Sep; 43(12 Suppl):1903-11. PubMed ID: 9788200
[No Abstract] [Full Text] [Related]
18. Subacute cerebellar degeneration and Lambert-Eaton myasthenic syndrome associated with antibodies to voltage-gated calcium channels: differential effect of immunosuppressive therapy on central and peripheral defects.
Goldstein JM; Waxman SG; Vollmer TL; Lang B; Johnston I; Newsom-Davis J
J Neurol Neurosurg Psychiatry; 1994 Sep; 57(9):1138-9. PubMed ID: 8089692
[No Abstract] [Full Text] [Related]
19. Cloning and characterization of a Lambert-Eaton myasthenic syndrome antigen.
Rosenfeld MR; Wong E; Dalmau J; Manley G; Posner JB; Sher E; Furneaux HM
Ann Neurol; 1993 Jan; 33(1):113-20. PubMed ID: 8494331
[TBL] [Abstract][Full Text] [Related]
20. Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes.
Lennon VA; Kryzer TJ; Griesmann GE; O'Suilleabhain PE; Windebank AJ; Woppmann A; Miljanich GP; Lambert EH
N Engl J Med; 1995 Jun; 332(22):1467-74. PubMed ID: 7739683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
